Protara Therapeutics, Inc. short interest in 2026
In 2026, Protara Therapeutics, Inc.'s disclosed short interest ran from 6.54% of shares outstanding on 15 Jan 2026 to 7.47% on 15 Sep 2026, a change of +0.93 percentage points. The year's high was 12.69% on 27 Feb 2026 and its low 6.54% on 15 Jan 2026, averaging 8.96% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.36 days on 31 Aug 2026. Full history: Protara Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 6.54% (15 Jan 2026)
- End of year
- 7.47% (15 Sep 2026)
- Change
- +0.93 pp
- High
- 12.69% (27 Feb 2026)
- Low
- 6.54% (15 Jan 2026)
- Average
- 8.96%
- Highest days to cover
- 12.36 (31 Aug 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 6.54% | 2.06 | |
| 30 Jan 2026 | 7.34% | 2.34 | |
| 13 Feb 2026 | 8.57% | 6.15 | |
| 27 Feb 2026 | 12.69% | 3.08 | |
| 13 Mar 2026 | 11.83% | 6.19 | 10-K filed, results (8-K) |
| 31 Mar 2026 | 10.26% | 6.14 | |
| 15 Apr 2026 | 10.62% | 11.15 | |
| 30 Apr 2026 | 11.09% | 9.57 | |
| 15 May 2026 | 6.91% | 5.61 | 10-Q filed, results (8-K) |
| 29 May 2026 | 10.89% | 6.17 | |
| 15 Jun 2026 | 8.26% | 6.55 | |
| 30 Jun 2026 | 8.02% | 5.12 | |
| 15 Jul 2026 | 8.40% | 6.72 | |
| 31 Jul 2026 | 8.31% | 11.47 | |
| 14 Aug 2026 | 7.68% | 12.03 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 7.50% | 12.36 | |
| 15 Sep 2026 | 7.47% | 10.34 |
See also: Protara Therapeutics, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.